WilmerHale has advised State Street Corporation. Cravath, Swaine & Moore LLP has advised the underwriters. State Street Corporation (SST) has concluded a public offering amounting to...
State Street Completes $500 Million Series L Preferred Stock Offering
Biogen to Acquire RayThera for Up to $1 Billion
Wilmer Cutler Pickering Hale and Dorr has advised Biogen. Biogen Inc. (Nasdaq: BIIB) announced that it has entered into a definitive agreement to acquire RayThera Inc.,...
Hemab Therapeutics Closes Upsized Initial Public Offering on Nasdaq
Wilmer Cutler Pickering Hale and Dorr has advised Hemab Therapeutics Holdings, Inc. Goodwin Procter has advised the underwriters. Hemab Therapeutics Holdings, Inc., a clinical-stage biotechnology company,...
Cue Biopharma’s $20 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Cue Biopharma, and Paul Hastings advised the underwriters on the offering. Cue Biopharma (Nasdaq: CUE), a clinical-stage biopharmaceutical company,...
Thermo Fisher’s $4.1 Billion Acquisition of Purification and Filtration Business from Solventum
Wilmer Cutler Pickering Hale and Dorr advised Thermo Fisher Scientific Inc. on the transaction, and Cleary Gottlieb Steen & Hamilton and Paksoy advised Solventum. Debevoise &...
Orna Therapeutics’ Acquisition of ReNAgade Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised Orna Therapeutics on the transaction. Orna Therapeutics, a biotechnology company, announced its acquisition of ReNAgade Therapeutics, a pioneer in...